These emerging medications , Tirzepatide , represent a groundbreaking advancement in addressing type 2 diabetes and possibly related conditions . They are categorized as GLP-1 receptor agonists , signifying they function to emulate the body's GLP-1 substance , enhancing glucose production and sup